Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kelsey-Leigh A. Garcia"'
Autor:
Ryan D. Cassaday, Lucas C. Zarling, Kelsey-Leigh A. Garcia, Olga Sala-Torra, Philip A. Stevenson, Christen H. Martino, Yajuan J. Liu, Min Fang, Mary-Elizabeth M. Percival, Anna B. Halpern, Pamela S. Becker, Vivian G. Oehler, Andrei R. Shustov, Jason P. Cooper, Johnnie J. Orozco, Paul C. Hendrie, Roland B. Walter, Jerald P. Radich, Lorinda A. Soma, Elihu H. Estey
Publikováno v:
Leukemia & Lymphoma. :1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22e372ead163c6b01fa18fbdbac6fc6b
https://doi.org/10.1080/10428194.2023.2189803
https://doi.org/10.1080/10428194.2023.2189803
Autor:
Anna B. Halpern, Eduardo P Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M. Percival, Ryan D. Cassaday, Vivian G. Oehler, Pamela S. Becker, Jacob S. Appelbaum, Janis L. Abkowitz, Johnnie J. Orozco, Sioban B. Keel, Paul C. Hendrie, Bart L. Scott, Cristina Ghiuzeli, Roland B. Walter, Elihu H. Estey
Publikováno v:
Blood. 140:8999-9001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::049673ff35d3ea778ed0cd1d0d007206
https://doi.org/10.1182/blood-2022-159882
https://doi.org/10.1182/blood-2022-159882
Autor:
Anna B. Halpern, Megan Othus, Genevieve Alcorn, Zahra Ali, Kelsey-Leigh A. Garcia, Mary-Elizabeth M. Percival, Siobán B. Keel, Ryan D. Cassaday, Pamela S. Becker, Elihu H. Estey, Roland B. Walter
Publikováno v:
Leukemia. 36:1386-1389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e9d6cedc0122e269c0ef1c5b08c820c
https://doi.org/10.1038/s41375-022-01524-1
https://doi.org/10.1038/s41375-022-01524-1
Autor:
Kelsey‐Leigh A. Garcia, Sindhu Cherian, Philip A. Stevenson, Christen H. Martino, Andrei R. Shustov, Pamela S. Becker, Mary‐Elizabeth M. Percival, Vivian G. Oehler, Anna B. Halpern, Roland B. Walter, Johnnie J. Orozco, Siobán B. Keel, Elihu H. Estey, Ryan D. Cassaday
Publikováno v:
Cancer. 128:1411-1417
Potential involvement of the central nervous system (CNS) by acute lymphoblastic leukemia is typically evaluated by a conventional cytospin (CC) of cerebrospinal fluid (CSF). Multiparameter flow cytometry (MFC) is generally more sensitive and specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c3a926da3c94bd6e2d27791bb38aac4
https://doi.org/10.1002/cncr.34073
https://doi.org/10.1002/cncr.34073
Autor:
Paul Nghiem, Kelsey-Leigh A. Garcia, Mary-Elizabeth M. Percival, Phillip A. Stevenson, Elihu H. Estey, Cameron J. Turtle, Jonathan R. Fromm, Ryan D. Cassaday
Publikováno v:
Blood Adv
The presence of measurable residual disease (MRD) in acute lymphoblastic leukemia (ALL) confers a poor prognosis. CD19-targeted immunotherapy is effective against MRD but is logistically challenging, potentially toxic, and not applicable to T-cell AL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106b117e94d42c7ed8a7c76217fe5a79
https://doi.org/10.1182/bloodadvances.2020002403
https://doi.org/10.1182/bloodadvances.2020002403
Autor:
Anna B, Halpern, Megan, Othus, Genevieve, Alcorn, Zahra, Ali, Kelsey-Leigh A, Garcia, Mary-Elizabeth M, Percival, Siobán B, Keel, Ryan D, Cassaday, Pamela S, Becker, Elihu H, Estey, Roland B, Walter
Publikováno v:
Leukemia. 36(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f948808f2129adca282f43f274d09904
https://pubmed.ncbi.nlm.nih.gov/35173273
https://pubmed.ncbi.nlm.nih.gov/35173273
Autor:
Elihu H. Estey, Andrei R. Shustov, Johnnie J. Orozco, Roland P Walter, Christen N. Martino, Colin D. Godwin, Sioban Keel, Vivian G. Oehler, Mary-Beth M. Percival, Pamela S. Becker, Ryan D. Cassaday, Philip A. Stevenson, Kelsey-Leigh A. Garcia, Anna B. Halpern, Sindhu Cherian
Publikováno v:
Blood. 136:28-30
BACKGROUND: CNS directed chemotherapy (chemo) reduces the risk of CNS relapse of ALL, but the optimal way to measure baseline CNS involvement is controversial. Baseline CSF testing can provide risk stratification and often dictates CNS prophylaxis (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae4539916f10948317ea7c72fe2402b1
https://doi.org/10.1182/blood-2020-137780
https://doi.org/10.1182/blood-2020-137780
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paul C. Hendrie, Mary-Elizabeth M. Percival, Jerry P. Radich, Yajuan J. Liu, Johnnie J. Orozco, Lorinda Soma, Vivian G. Oehler, Min Fang, Roland B. Walter, Olga Sala-Torra, Andrei R. Shustov, Kelsey-Leigh A. Garcia, Anna B. Halpern, Pamela S. Becker, Christen H. Martino, Elihu H. Estey, Philip A. Stevenson, Jason P. Cooper, Ryan D. Cassaday
Publikováno v:
Blood. 138:4397-4397
BACKGROUND: Novel agents added to front-line treatments for adult ALL yield high rates of measurable residual disease (MRD) negativity and survival. However, these approaches are infeasible outside large centers and in lower-resource settings. HyperC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c84e6e1b17446900035591d34992866
https://doi.org/10.1182/blood-2021-145648
https://doi.org/10.1182/blood-2021-145648
Autor:
Pamela S. Becker, Jerald P. Radich, Olga Sala-Torra, Kelsey-Leigh A. Garcia, Anna B. Halpern, Lorinda Soma, Elihu H. Estey, Ryan D. Cassaday, Andrei R. Shustov, Christen N. Heye, Mary-Elizabeth M. Percival, Philip A. Stevenson, Vivian G. Oehler
Publikováno v:
Blood. 132:1419-1419
BACKGROUND: HyperCVAD is used commonly in adult ALL but can be difficult for older or infirm patients (pts) to tolerate (JCO 2000, p. 547; Cancer 2008, p. 2097). At our center, only 50% who receive it reach a minimal residual disease negative (MRD-)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c4c34f51181ffeb580e08af0a1beba8
https://doi.org/10.1182/blood-2018-99-110661
https://doi.org/10.1182/blood-2018-99-110661